LAKE HAVASU CITY, Ariz. — Many anglers like to escape to the water, leaving the cares of the world back on land.
Jay Evans is certainly one of them, but he knows that a day of fishing always is followed by a hard day of work, and it’s not necessarily work he can wait a day to tackle.
Evans is the CEO of Inimmune, a biotech company that for the past five years has been at the vanguard of vaccine research, better protecting people from everything from allergies to cancer to COVID-19. He co-founded the company in 2016 at the same time he and 14 other scientists went to work at the University of Montana. There, they started what is known as the Center for Translational Medicine, where they take discoveries in the lab and turn them into medical treatments that help people across the world.